Glaukos (GKOS) EBITDA (2014 - 2026)

Glaukos (GKOS) has 13 years of EBITDA data on file, last reported at -$19.9 million in Q1 2026.

• EBITDA for Q1 2026 came in at -$19.9 million, up 3.98% year-over-year; the trailing twelve-month figure through Mar 2026 was -$39.7 million (down 225.82% YoY), and the FY2025 annual result was -$40.5 million, down 32.58% from the prior year.
• EBITDA fell to -$19.9 million in Q1 2026 per GKOS's latest filing, from $19.2 million in the prior quarter.
• Over five years, EBITDA peaked at $63.1 million in Q4 2024 and troughed at -$39.1 million in Q1 2024.
• A 5-year average of -$17.8 million and a median of -$24.7 million in 2024 frame the typical range for EBITDA.
• The sharpest annual moves came in 2023 and 2024: EBITDA sank 436.94% in 2023, then surged 263.44% in 2024.
• A 5-year view of EBITDA shows it stood at -$33.7 million in 2022, then fell by 14.49% to -$38.6 million in 2023, then surged by 263.44% to $63.1 million in 2024, then slumped by 69.59% to $19.2 million in 2025, then tumbled by 203.45% to -$19.9 million in 2026.
• Business Quant data shows GKOS's EBITDA at -$19.9 million in Q1 2026, $19.2 million in Q4 2025, and -$16.4 million in Q3 2025.